Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer

In estrogen receptor (ER)-positive breast cancer, changes in biomarker expression after neoadjuvant therapy indicate the therapeutic response and are prognostic. However, there is limited information about the biomarker alteration caused by neoadjuvant endocrine therapy in ER-positive and human epid...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Mengping, You, Chong, Song, Qianqian, Hu, Lina X. J., Guo, Zhaorong, Yao, Qian, Hou, Wei, Sun, Wei, Liang, Baosheng, Zhou, Xiao-Hua, Liu, Yiqiang, Hu, Taobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866043/
https://www.ncbi.nlm.nih.gov/pubmed/36676023
http://dx.doi.org/10.3390/life13010074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866043/
https://www.ncbi.nlm.nih.gov/pubmed/36676023
http://dx.doi.org/10.3390/life13010074

Ejemplares similares